BioSpace News Archive

BioCapital

Who’s on Top: The Current Leaders in Biopharma Diversity

For BioSpace’s recent Ideal Employer report, life sciences professionals weighed in on the topic.

November 4, 2019
·
3 min read
·
Kymberlie Krieger
Business

Are Diversity and Inclusion Part of Your Organization’s Culture?

In the United States, an organization’s culture has been at the forefront of talent attraction and employee engagement initiatives for more than a decade.

November 4, 2019
·
4 min read
·
By Dana Dunbar SHRM-SCP
Policy

AVEO Stunned As FDA Suggests Another Delay in Filing NDA for RCC Drug

AVEO said it received preliminary feedback from the FDA and the regulatory agency recommended not filing the NDA at this time based on its assessment of the totality of evidence in the Phase III trial.

November 4, 2019
·
2 min read
·
Alex Keown
Policy

ORYX Provides Strategic Update on the Clinical Development of Oncolytic Virotherapy ParvOryx

Endorsement of pivotal development program in recurrent glioblastoma (rGBM) from both EMA and FDA

November 4, 2019
·
4 min read
Genetown

Summit Therapeutics Recognises C. difficile Awareness Month

Company to Highlight Potential of Phase 3 Precision Antibiotic Ridinilazole at the 7th Annual C. diff. Conference and Health EXPO

November 4, 2019
·
6 min read
Pharm Country

New 3D Bioprinting Technique Utilizes Vasculature that Closely Simulates Human Skin

Researchers at Rensselaer Polytechnic Institute developed a technique for 3D printing living skin that also has blood vessels.

November 4, 2019
·
2 min read
·
Mark Terry
ADC Therapeutics Announces Publication of ADCT-402 Data in Clinical Cancer Research

Data support potential of ADCT-402 to become an important treatment option for patients with relapsed or refractory diffuse large B-cell lymphoma

November 4, 2019
·
5 min read
Deals

Sygnature Discovery invests in high-throughput screening capability

Sygnature Discovery has added in-house high-throughput screening (HTS) to its range of drug discovery services.

November 4, 2019
·
2 min read
Drug Development

Esperion Announces Pooled Analyses from Phase 3 LDL-C Lowering Development Program of Bempedoic Acid to be Presented at the American Heart Association 2019 Scientific Sessions

Esperion announced that pooled analyses from four Phase 3 clinical trials of bempedoic acid will be presented at the American Heart Association Scientific Sessions in Philadelphia on Sunday, November 17, 2019.

November 4, 2019
·
7 min read
Pharm Country

Bioprinting advanced skin architecture complete with blood vessels using CELLINK technology

A new study from Rensselaer Polytechnic Institute successfully demonstrates the use of CELLINK technology to produce living skin models.

November 4, 2019
·
1 min read